Literature DB >> 31965234

[Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis].

M Bach1, S Schob2, C Baerwald3.   

Abstract

A 78-year-old woman with rheumatoid arthritis on TNF-α inhibitor, methotrexate and prednisolone presented with severe but unspecific symptoms such as leg weakness, shivering, bifrontal headache, nausea and staggering. The broad range of differential diagnoses lead to intricate and time-consuming diagnostic procedures. Serology, magnetic resonance imaging and microbiological investigations represent important steps to make the final diagnosis of cerebral toxoplasmosis. Both diagnostic approach and therapy require close cooperation of different disciplines. Therapies of rheumatoid arthritis as well as of toxoplasmosis are based on a long-term treatment and could be associated with numerous harmful side effects. Continuous monitoring and permanent adjustment of therapy regimes are therefore mandatory.

Entities:  

Keywords:  Antirheumatic agents; Immunosuppression; Opportunistic infections; Toxoplasmosis, cerebral; Tumor necrosis factor alpha inhibitors

Mesh:

Substances:

Year:  2020        PMID: 31965234     DOI: 10.1007/s00108-019-00727-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

Review 1.  The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis.

Authors:  Nurit Katz-Agranov; Saakshi Khattri; Gisele Zandman-Goddard
Journal:  Autoimmun Rev       Date:  2015-04-12       Impact factor: 9.754

2.  Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).

Authors:  Hauke Thomsen; Chiara Campo; Niels Weinhold; Miguel Inacio da Silva Filho; Luděk Pour; Evžen Gregora; Pavel Vodicka; Ludmila Vodickova; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Christian Langer; Roman Hajek; Hartmut Goldschmidt; Kari Hemminki; Asta Försti
Journal:  Eur J Haematol       Date:  2017-05-24       Impact factor: 2.997

Review 3.  Progressive multifocal leukoencephalopathy - epidemiology, immune response, clinical differences, treatment.

Authors:  S Snopková; P Štourač; L Fašaneková; M Mihalčin; K Havlíčková; R Svačinka; P Volfová; P Snopek; P Husa
Journal:  Epidemiol Mikrobiol Imunol       Date:  2019       Impact factor: 0.444

Review 4.  A clinicopathological classification of granulomatous disorders.

Authors:  D G James
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

5.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

6.  Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis.

Authors:  Swaroopa Pulivarthi; Rwoof A Reshi; Carl T McGary; Murali Krishna Gurram
Journal:  Intern Med       Date:  2015-06-01       Impact factor: 1.271

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

Review 8.  Paraneoplastic neurological syndromes.

Authors:  F Leypoldt; K-P Wandinger
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 9.  Sarcoidosis.

Authors:  Hilario Nunes; Diane Bouvry; Paul Soler; Dominique Valeyre
Journal:  Orphanet J Rare Dis       Date:  2007-11-19       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.